My watch list
my.chemeurope.com  
Login  

19 Current news of Bayer HealthCare

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

After a good third quarter: Bayer confirms Group outlook

Net income more than doubled to EUR 642 million (plus 125.3 percent)

01-Nov-2011

The Bayer Group achieved further sales growth and significantly increased earnings in the third quarter of 2011. “It was a good quarter for Bayer,” Management Board Chairman Dr. Marijn Dekkers said Thursday at the presentation of the interim report. He described the continuing growth momentum in ...

more

Bayer off to a successful start to 2011

First quarter of 2011: all subgroups lift sales and earnings

29-Apr-2011

The Bayer Group got off to a successful start to 2011. “All three subgroups contributed to the strong start to the year with sales and earnings increases,” Bayer CEO Dr. Marijn Dekkers explained on Thursday when the company’s first-quarter results were released. He was especially pleased at how ...

more

Bayer focuses resources on growth and innovation

Planned net reduction of about 2,000 jobs worldwide by the end of 2012

23-Nov-2010

Bayer plans to invest its resources even more systematically in growing the company and enhancing its innovative capability. The focus will be on researching, developing and marketing new products, particularly in HealthCare and CropScience, and on expanding activities in the emerging markets. ...

more

Bayer Strengthens Research and Development

Pharmaceutical pipeline is well filled, with 50 projects currently in phases I to III of clinical testing

16-Dec-2008

The Bayer Group is to further expand its research and development activities despite the current financial and economic crisis. “The task now is to set the right course. Only through innovation can our company generate the growth that is essential to safeguard its sustained success,” said Werner ...

more

Bayer completes acquisition of U.S. biologics manufacturing facility from Novartis

17-Sep-2007

Bayer Schering Pharma AG, Germany, has completed the acquisition of a biologics manufacturing facility in Emeryville, California from Novartis. Bayer will manufacture its multiple sclerosis drug Betaseron® at the Emeryville site, retain full control of all manufacturing and process technology ...

more

Bayer HealthCare announces concrete plans for the global synergy goals and job cuts

06-Mar-2007

Bayer HealthCare published concrete plans regarding the previously announced synergy goals. The integration of the activities of the former Schering AG, Germany, with the Pharma division of Bayer HealthCare shall result in annual savings of EUR 700 million from 2009. Adjustments to personnel ...

more

Bayer HealthCare strengthens presence in Eastern Europe

More than 200 staff for Marketing and Sales integrated in Russia, Belarus, the Ukraine and Kazakhstan

22-Feb-2007

Bayer HealthCare has taken over the marketing and distribution network of its partner Pharmonyx Ltd. in Russia, Belarus, the Ukraine and Kazakhstan. Pharmonyx has been responsible for marketing and distributing BHC's products in these countries since 1999. Both parties have agreed to refrain from ...

more

Bayer Outlines New Global R&D Structures

U.S. Pharma Sites and Future Headquarters

13-Nov-2006

Bayer HealthCare announced a structural realignment of its global pharmaceutical research and development organization. The company also outlined its future U.S. pharma site plan, and said that New Jersey will be home to its U.S. headquarters for pharmaceuticals. These moves follow Bayer's ...

more

Bayer HealthCare Acquires Western OTC Cough and Cold Business of Topsun Science and Technology

27-Oct-2006

Bayer HealthCare (BHC) and Topsun Science and Technology Co., Ltd. together announced that BHC's Consumer Care Division has signed an agreement in China to acquire the Western over-the-counter (OTC) cough and cold portfolio of Topsun Science and Technology Qidong Gaitianli Pharmaceutical Co., ...

more

Bayer and Schering optimistic about their common future

23-Jun-2006

Following the success of Bayer's takeover offer for Schering, the two companies are confident about their common future. "We will combine two successful pharmaceutical companies to form a single, even more powerful unit and create a leading global enterprise," said Bayer Management Board Chairman ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE